HCC cell invasiveness was inhibited in vitro by VEGF modulation, which was mediated by the suppression of EphA3, suggesting potential as a prognostic marker and target for HCC treatment [87]. The gene discussed is EPHA3; the disease is hepatocellular carcinoma.